Guangzhou Houbao Investment Partnership (Limited Partnership) signed a share transfer agreement to acquire 5.04% stake in Xiamen Amoytop Biotech Co., Ltd. (SHSE:688278) from Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) for approximately CNY 410 million on March 16, 2022. As per the transaction, Guangzhou Houbao Investment Partnership (Limited Partnership) will acquire 20.5 million shares at CNY 20.16 per share . The transaction is subject to approval by Shanghai Stock Exchange.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
53.55 CNY | -3.06% | -7.05% | +2.29% |
04-22 | Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-18 | China Stocks Advance Over Positive Economic Data; Amoytop Biotech Rises 6% | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.29% | 3B | |
+2.99% | 95.18B | |
-4.34% | 37.55B | |
-10.41% | 33.75B | |
+75.79% | 28.2B | |
-14.61% | 15.63B | |
-3.46% | 13.63B | |
-12.31% | 11.5B | |
+184.77% | 10.81B | |
-54.13% | 9.23B |
- Stock Market
- Equities
- 688278 Stock
- News Xiamen Amoytop Biotech Co., Ltd.
- Guangzhou Houbao Investment Partnership (Limited Partnership) signed a share transfer agreement to acquire 5.04% stake in Xiamen Amoytop Biotech Co., Ltd. from Tonghua Dongbao Pharmaceutical Co., Ltd. for approximately CNY 410 million.